Renaissance Technologies’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-79,500
Closed -$204K 4492
2022
Q3
$204K Sell
79,500
-425,373
-84% -$1.35M ﹤0.01% 3376
2022
Q2
$1.22M Buy
+504,873
New +$1.33M ﹤0.01% 2579
2021
Q3
Sell
-111,572
Closed -$1.02M 3933
2021
Q2
$1.02M Buy
+111,572
New +$1.03M ﹤0.01% 2656
2021
Q1
Sell
-251,982
Closed -$993K 3796
2020
Q4
$993K Sell
251,982
-84,418
-25% -$255K ﹤0.01% 2505
2020
Q3
$891K Buy
336,400
+197,827
+143% +$734K ﹤0.01% 2578
2020
Q2
$920K Buy
138,573
+89,073
+180% +$600K ﹤0.01% 2578
2020
Q1
$288K Buy
+49,500
New +$416K ﹤0.01% 2994

Other funds holding GRTS

Renaissance Technologies's GRTS Position: Q4 2022 in Review

Renaissance Technologies sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q4 2022, closing a stake of 79,500 shares — an estimated $204K sold.

Renaissance Technologies first reported a position in GRTS in Q1 2020 and held it in 7 quarters. The position peaked at $1.22M in Q2 2022. 91 funds tracked by Wall St. Rank hold GRTS as of Q4 2022.

  • Renaissance Technologies reported no remaining Gritstone bio, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Renaissance Technologies sold 79,500 Gritstone bio, Inc. Common Stock shares in Q4 2022, an estimated $204K.
  • Renaissance Technologies first reported a position in Gritstone bio, Inc. Common Stock in Q1 2020 and held it in 7 quarters.
  • Renaissance Technologies's Gritstone bio, Inc. Common Stock position peaked at $1.22M in Q2 2022.
  • 91 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q4 2022.

Based on Renaissance Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.